This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.

​​​​​​​Who is the CRESEMBA® patient?

CRESEMBA may be an appropriate treatment option for a range of different patients. These could include patients in need of oral therapy, those at risk of particular drug-drug interactions associated with other azoles or those with renal impairment.​​​​​​​

Patient case studies illustrating use of CRESEMBA (isavuconazole) in a clinical setting

Lisa Nwankwo - Specialist Pharmacist, Antimicrobials

Patient case study illustrating use of isavuconazole in a clinical setting: A case of pulmonary mucormycosis

Card CTA

** This is an optional area where footnotes can live.

Lisa Nwankwo - Specialist Pharmacist, Antimicrobials

Patient case study illustrating use of isavuconazole in a clinical setting: Invasive aspergillosis in cystic fibrosis

Card CTA

** This is an optional area where footnotes can live.

Lisa Nwankwo - Specialist Pharmacist, Antimicrobials

Patient case study illustrating use of isavuconazole in a clinical setting:  A complex ITU patient

Card CTA

** This is an optional area where footnotes can live.

Amit Patel - Consultant in Leukaemia, stem cell transplantation, cellular therapy and intensive care medicine

Clinical experience with CRESEMBA (isavuconazole): 50-year-old female pre-allogenic stem cell transplantation with suspected invasive aspergillosis

Card CTA

** This is an optional area where footnotes can live.

Amit Patel - Consultant in Leukaemia, stem cell transplantation, cellular therapy and intensive care medicine

Clinical experience with CRESEMBA (isavuconazole): 56-year-old female pre-allogenic stem cell transplantation with suspected invasive aspergillosis

Card CTA

** This is an optional area where footnotes can live.

Amit Patel - Consultant in Leukaemia, stem cell transplantation, cellular therapy and intensive care medicine

Clinical experience with CRESEMBA (isavuconazole): 66-year-old pre-allogenic stem cell transplantation with suspected invasive aspergillosis

Card CTA

** This is an optional area where footnotes can live.

Nelun Perera, Consultant Microbiologist

Sharing clinical experience of CRESEMBA (isavuconazole) in the UK

Footnotes

AML acute myeloid leukaemia, HIV human immunodeficiency virus, CLL chronic lymphocytic leukaemia

Explore more

Invasive Aspergillosis

An overview of the SECURE trial for CRESEMBA (isavuconazole).

Learn more

Mucormycosis

An overview of the VITAL trial for CRESEMBA (isavuconazole).

Learn more



​​​​​​Prescribing Information

Cresemba (isavuconazole)
Great Britain

Cresemba (isavuconazole) 100mg hard capsules
Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion 

Northern Ireland
Cresemba (Isavuconazole) 100mg hard capsules and Cresemba (Isavuconazole) 200mg powder for concentrate for solution for infusion

Vfend (voriconazole)
Great Britain
​​​​​​​Vfend (voriconazole) 50mg film coated tablets
Vfend (voriconazole) 200mg film coated tablets
Vfend (voriconazole) 200mg powder for solution for infusion
Vfend (voriconazole) 40mg/ml powder for oral suspension


Northern Ireland
​​​​​​​
Vfend (voriconazole): 50mg film coated tablets, 200mg film coated tablets, 200mg powder for solution for infusion & 40mg/ml powder for oral suspension 

Meronem (meropenem trihydrate)IV 1g
Meronem (meropenem trihydrate) IV 500mg

Tazocin (piperacillin sodium, tazobactam sodium)   2g/0.25g powder for solution for infusion
Tazocin (piperacillin sodium, tazobactam sodium)-  4g/0.5g powder for solution for infusion

Tygacil® (tigecycline) 50 mg powder for solution for infusion

Diflucan (fluconazole) - 10mg/ml powder for oral suspension
Diflucan (fluconazole) - 150mg capsules
Diflucan (fluconazole)  -  200mg hard capsules
Diflucan (fluconazole)  -  40mg/ml powder for oral suspension
Diflucan (fluconazole) -  50mg hard capsules

Ecalta (anidulafungin) -  100mg powder for concentrate for solution for infusion

Cytarabine 20 mg/mL solution for infusion or injection
Cytarabine 100 mg/mL solution for infusion or injection
Cytarabine injection solution 20 mg/mL 
Cytarabine injection solution 100 mg/mL solution

Ciprofloxacin (ciprofloxacin lactate) 2 mg/ml solution for infusion - SPC
Legal Category: POM Basic NHS Price: 10 bags £200.00 

Amikacin (amikacin sulfate) 500mg/2ml solution for injection - SPC
Legal Category: POM Basic NHS Price: 5 vial pack £60.00

Aciclovir (aciclovir sodium) 250 mg/ 10 ml solution for infusion – SPC 
Legal Category: POM. Basic NHS Cost: 5 vials £50.00

PP-CRB-GBR-1215. August 2021

Antifungal Stewardship

Support for your Programme

Training

 Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No